Literature DB >> 19275932

Reciprocal regulation of Abl and receptor tyrosine kinases.

Divyamani Srinivasan1, David M Kaetzel, Rina Plattner.   

Abstract

Previously, we showed that Abl kinases (c-Abl, Arg) are activated downstream of PDGF in a manner dependent on Src kinases and PLC-gamma1, and promote PDGF-mediated proliferation and migration of fibroblasts. We additionally demonstrated that Abl kinases bind directly to PDGFR-beta via their SH2 domains.In this study, we extend these findings by demonstrating that Abl kinases also are activated downstream of aPDGF autocrine growth loop in glioblastoma cells, indicating that the PDGFR-Abl signaling pathway also is likely to be important in glioblastoma development and/or progression.We recently showed that Abl kinases are highly active in many breast cancer cell lines, and the Her-2 receptor tyrosine kinase contributes to c-Abl and Arg kinase activation. In this study, we show that Abl kinase SH2 domains bind directly to Her-2, and like PDGFR-beta , Her-2 directly phosphorylates c-Abl. Previously, we demonstrated that PDGFR-beta directly phosphorylates Abl kinases in vitro, and Abl kinases reciprocally phosphorylate PDGFR-beta . Here, we show that PDGFR-beta-phosphorylation of Abl kinases has functional consequences as PDGFR-beta phosphorylates Abl kinases on Y245 and Y412, sites known to be required for activation of Abl kinases. Moreover, PDGFR-beta phosphorylates Arg on two additional unique sites whose function is unknown. Importantly, we also show that Abl-dependent phosphorylation of PDGFR-beta has functional and biological significances. c-Abl phosphorylates three tyrosine residues on PDGFR-beta (Y686, Y934, Y970), while Arg only phosphorylatesY686. Y686 and Y934 reside in PDGFR-beta catalytic domains, while Y970 is in the C-terminal tail. Using site-directed mutagenesis, we show that Abl-dependent phosphorylation of PDGFR-beta activates PDGFR-beta activity, in vitro, but serves to downregulate PDGFR-mediated chemotaxis. These data are exciting as they indicate that Abl kinases not only are activated by PDGFR and promote PDGFR-mediated proliferation and migration,but also act in an intricate negative feedback loop to turn-off PDGFR-mediated chemotaxis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19275932      PMCID: PMC2701649          DOI: 10.1016/j.cellsig.2009.03.003

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  32 in total

1.  The Abl-related gene (Arg) nonreceptor tyrosine kinase uses two F-actin-binding domains to bundle F-actin.

Authors:  Y Wang; A L Miller; M S Mooseker; A J Koleske
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

2.  Abl tyrosine kinase regulates endocytosis of the epidermal growth factor receptor.

Authors:  Barbara Tanos; Ann Marie Pendergast
Journal:  J Biol Chem       Date:  2006-08-29       Impact factor: 5.157

3.  c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF.

Authors:  R Plattner; L Kadlec; K A DeMali; A Kazlauskas; A M Pendergast
Journal:  Genes Dev       Date:  1999-09-15       Impact factor: 11.361

4.  Identification of the receptor-associated signaling enzymes that are required for platelet-derived growth factor-AA-dependent chemotaxis and DNA synthesis.

Authors:  S Rosenkranz; K A DeMali; J A Gelderloos; C Bazenet; A Kazlauskas
Journal:  J Biol Chem       Date:  1999-10-01       Impact factor: 5.157

5.  c-Abl has high intrinsic tyrosine kinase activity that is stimulated by mutation of the Src homology 3 domain and by autophosphorylation at two distinct regulatory tyrosines.

Authors:  B B Brasher; R A Van Etten
Journal:  J Biol Chem       Date:  2000-11-10       Impact factor: 5.157

6.  Activation of Abl tyrosine kinases promotes invasion of aggressive breast cancer cells.

Authors:  Divyamani Srinivasan; Rina Plattner
Journal:  Cancer Res       Date:  2006-06-01       Impact factor: 12.701

Review 7.  Cytoplasmic signalling by the c-Abl tyrosine kinase in normal and cancer cells.

Authors:  Audrey Sirvent; Christine Benistant; Serge Roche
Journal:  Biol Cell       Date:  2008-11       Impact factor: 4.458

8.  SHP-2 is a novel target of Abl kinases during cell proliferation.

Authors:  Sayan Mitra; Carol Beach; Gen-Sheng Feng; Rina Plattner
Journal:  J Cell Sci       Date:  2008-09-30       Impact factor: 5.285

9.  Oncogenic activation of c-Abl in non-small cell lung cancer cells lacking FUS1 expression: inhibition of c-Abl by the tumor suppressor gene product Fus1.

Authors:  J Lin; T Sun; L Ji; W Deng; J Roth; J Minna; R Arlinghaus
Journal:  Oncogene       Date:  2007-05-07       Impact factor: 9.867

10.  Aggressive breast cancer cells are dependent on activated Abl kinases for proliferation, anchorage-independent growth and survival.

Authors:  D Srinivasan; J T Sims; R Plattner
Journal:  Oncogene       Date:  2007-08-13       Impact factor: 9.867

View more
  22 in total

1.  The Ron receptor tyrosine kinase activates c-Abl to promote cell proliferation through tyrosine phosphorylation of PCNA in breast cancer.

Authors:  H Zhao; M-S Chen; Y-H Lo; S E Waltz; J Wang; P-C Ho; J Vasiliauskas; R Plattner; Y-L Wang; S-C Wang
Journal:  Oncogene       Date:  2013-04-01       Impact factor: 9.867

2.  The c-Abl-MST1 signaling pathway mediates oxidative stress-induced neuronal cell death.

Authors:  Lei Xiao; Dongmei Chen; Peng Hu; Junbing Wu; Weizhe Liu; Yanhong Zhao; Mou Cao; Yuan Fang; Wenzhi Bi; Zheng Zheng; Jian Ren; Guangju Ji; Yan Wang; Zengqiang Yuan
Journal:  J Neurosci       Date:  2011-06-29       Impact factor: 6.167

3.  Structural insights into the tyrosine phosphorylation-mediated inhibition of SH3 domain-ligand interactions.

Authors:  Balázs Merő; László Radnai; Gergő Gógl; Orsolya Tőke; Ibolya Leveles; Kitti Koprivanacz; Bálint Szeder; Metta Dülk; Gyöngyi Kudlik; Virág Vas; Anna Cserkaszky; Szabolcs Sipeki; László Nyitray; Beáta G Vértessy; László Buday
Journal:  J Biol Chem       Date:  2019-01-18       Impact factor: 5.157

4.  An EGFR-Src-Arg-cortactin pathway mediates functional maturation of invadopodia and breast cancer cell invasion.

Authors:  Christopher C Mader; Matthew Oser; Marco A O Magalhaes; Jose Javier Bravo-Cordero; John Condeelis; Anthony J Koleske; Hava Gil-Henn
Journal:  Cancer Res       Date:  2011-01-21       Impact factor: 12.701

Review 5.  ABL tyrosine kinases: evolution of function, regulation, and specificity.

Authors:  John Colicelli
Journal:  Sci Signal       Date:  2010-09-14       Impact factor: 8.192

6.  Crk and ABI1: binary molecular switches that regulate abl tyrosine kinase and signaling to the cytoskeleton.

Authors:  Sajjad Hossain; Patrycja M Dubielecka; Aleksander F Sikorski; Raymond B Birge; Leszek Kotula
Journal:  Genes Cancer       Date:  2012-05

7.  Activation of abl family kinases in solid tumors.

Authors:  Sourik S Ganguly; Rina Plattner
Journal:  Genes Cancer       Date:  2012-05

8.  ErbB2 overexpression upregulates antioxidant enzymes, reduces basal levels of reactive oxygen species, and protects against doxorubicin cardiotoxicity.

Authors:  Frances Belmonte; Samarjit Das; Polina Sysa-Shah; Vidhya Sivakumaran; Brian Stanley; Xin Guo; Nazareno Paolocci; Miguel A Aon; Masaki Nagane; Periannan Kuppusamy; Charles Steenbergen; Kathleen Gabrielson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-08-07       Impact factor: 4.733

9.  Phosphatase of regenerating liver 3 (PRL3) provokes a tyrosine phosphoproteome to drive prometastatic signal transduction.

Authors:  Chad D Walls; Anton Iliuk; Yunpeng Bai; Mu Wang; W Andy Tao; Zhong-Yin Zhang
Journal:  Mol Cell Proteomics       Date:  2013-09-12       Impact factor: 5.911

10.  The Endocytic Fate of the Transferrin Receptor Is Regulated by c-Abl Kinase.

Authors:  Hong Cao; Barbara Schroeder; Jing Chen; Micah B Schott; Mark A McNiven
Journal:  J Biol Chem       Date:  2016-05-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.